HWM
PRAX icon

Hemington Wealth Management’s Praxis Precision Medicines PRAX Stock Holding History

Hemington Wealth Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1K Hold
30
– – ﹤0.01% 1475
2025
Q2 		$1K Hold
30
– – ﹤0.01% 1444
2025
Q1 		$1K Buy
+30
New +$1.87K ﹤0.01% 1434

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Hemington Wealth Management's PRAX Position: Q3 2025 in Review

Hemington Wealth Management held its Praxis Precision Medicines (PRAX) position steady in Q3 2025 at 30 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1475.

Hemington Wealth Management first reported a position in PRAX in Q1 2025 and has held it in 3 quarters since. 152 funds tracked by Wall St. Rank hold PRAX as of Q3 2025.

  • Hemington Wealth Management held 30 shares of Praxis Precision Medicines worth $1K as of Q3 2025.
  • Hemington Wealth Management left its Praxis Precision Medicines share count unchanged in Q3 2025.
  • Praxis Precision Medicines made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1475 holding.
  • Hemington Wealth Management first reported a position in Praxis Precision Medicines in Q1 2025 and has held it in 3 quarters since.
  • 152 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.